niceritrol has been researched along with Hyperlipoproteinemia Type II in 3 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventeen patients with heterozygous familial hypercholesterolemia were sequentially treated with: a low cholesterol, fat restricted diet; diet and probucol (500 mg/day); and diet, probucol and niceritrol (1500 mg/day)." | 1.28 | New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia. ( Fukushima, N; Ozaki, I; Sakai, T; Setoguchi, Y; Yamamoto, K; Yanagita, T, 1991) |
| "Niceritrol treatment significantly reduced the Chol/TG ratio in VLDL while no such effect was seen during clofibrate administration." | 1.26 | Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease. ( Borberg, J; Gustafsson, IB; Lithell, H; Vessby, B, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kibata, M | 1 |
| Ishida, M | 1 |
| Asano, K | 1 |
| Uehara, H | 1 |
| Saito, K | 1 |
| Fuchimoto, T | 1 |
| Ugaki, K | 1 |
| Murakami, H | 1 |
| Matoba, K | 1 |
| Kotakemori, Y | 1 |
| Shirai, K | 1 |
| Yoshioka, H | 1 |
| Nanba, M | 1 |
| Yasuda, M | 1 |
| Ishizaki, M | 1 |
| Kitagawa, N | 1 |
| Ikejiri, K | 1 |
| Inohara, R | 1 |
| Lee, BJ | 1 |
| Saino, S | 1 |
| Sakado, J | 1 |
| Matuzaka, H | 1 |
| Numata, K | 1 |
| Mandai, M | 1 |
| Miyake, K | 1 |
| Nakamura, K | 1 |
| Vessby, B | 1 |
| Lithell, H | 1 |
| Gustafsson, IB | 1 |
| Borberg, J | 1 |
| Yamamoto, K | 1 |
| Fukushima, N | 1 |
| Ozaki, I | 1 |
| Setoguchi, Y | 1 |
| Yanagita, T | 1 |
| Sakai, T | 1 |
3 other studies available for niceritrol and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Clinical study of niceritrol on serum lipids in the treatment of hyperlipidemia.
Topics: Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipide | 1980 |
Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipopr | 1979 |
New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
Topics: Adult; Aged; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; | 1991 |